首页 >
法规速递
-
Document: Highlight report - Combination Products Operational Group (COMBO) - In Vitro Diagnostics stream-2026/1/7
2026-01-08查看详情 > -
Page: Extended EudraVigilance medicinal product dictionary (XEVMPD) training-2026/2/11
2026-02-12查看详情 > -
Document: Overview of comments received on the draft Qualification opinion for Molecule-independent device bridging approach (MIDBA)-2026/3/20
2026-03-23查看详情 > -
Document: Breakthrough status request: Template for applicants for breakthrough medical devices pilot-2026/4/24
2026-04-27查看详情 > -
Document: Checklist for the submission of Day 215 product information annexes for a post-opinion linguistic review (Word file)-2026/6/5
2026-06-08查看详情 > -
Document: Minutes of the HMPC meeting 4-6 May 2026-2026/7/17
2026-07-19查看详情 > -
国家药监局关于启用《出口欧盟原料药证明文件》和《药品出口销售证明》电子证明的公告 （2022年第95号）-2022/10-31
2022-11-14查看详情 > -
国家药监局药审中心关于发布《药物临床试验期间安全性数据快速报告常见问答（2.0版）》的通告（2023年第17号）-2023/03/17
2023-03-17查看详情 > -
Final Guidance: Considerations for the Conduct of Clinical Trials of Medical Products During Major Disruptions Due to Disasters and Public Health -2023/9/20
2023-09-21查看详情 > -
Document: Checklist for initial notifications for parallel distribution: guidance for industry-2025/1/6
2025-01-07查看详情 >
